AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738,963 | -1.2% | 60,770 | +2.0% | 0.01% | 0.0% |
| Q2 2023 | $748,036 | +10.5% | 59,557 | -2.5% | 0.01% | 0.0% |
| Q1 2023 | $677,089 | -6.6% | 61,054 | +2.9% | 0.01% | -14.3% |
| Q4 2022 | $724,810 | +21.6% | 59,362 | +4.0% | 0.01% | +16.7% |
| Q3 2022 | $596,000 | -2.5% | 57,100 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $611,000 | +7.0% | 56,916 | -5.5% | 0.01% | +20.0% |
| Q1 2022 | $571,000 | -13.9% | 60,256 | +5.0% | 0.01% | 0.0% |
| Q4 2021 | $663,000 | +19.7% | 57,394 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $554,000 | 0.0% | 57,978 | +0.9% | 0.01% | 0.0% |
| Q2 2021 | $554,000 | -17.9% | 57,479 | -15.8% | 0.01% | -16.7% |
| Q1 2021 | $675,000 | -56.7% | 68,272 | +1.1% | 0.01% | -57.1% |
| Q4 2020 | $1,560,000 | +57.9% | 67,544 | -3.5% | 0.01% | +40.0% |
| Q3 2020 | $988,000 | +14.0% | 69,971 | +21.7% | 0.01% | -16.7% |
| Q2 2020 | $867,000 | +56.8% | 57,512 | -3.9% | 0.01% | +20.0% |
| Q1 2020 | $553,000 | – | 59,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |